Filing Details
- Accession Number:
- 0000874015-13-000068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-26 19:46:19
- Reporting Period:
- 2013-06-24
- Filing Date:
- 2013-06-26
- Accepted Time:
- 2013-06-26 19:46:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 897667 | T Stanley Crooke | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-06-24 | 16,270 | $25.16 | 809,121 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2013-06-24 | 13,730 | $25.22 | 795,391 | No | 4 | S | Indirect | By Trust |
| Common Stock | Acquisiton | 2013-06-25 | 10,435 | $6.81 | 12,096 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-25 | 10,435 | $28.32 | 1,661 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-25 | 19,565 | $6.81 | 21,226 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-25 | 19,565 | $27.87 | 1,661 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-26 | 20,000 | $6.81 | 21,661 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-26 | 20,000 | $27.10 | 1,661 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-06-26 | 10,000 | $26.70 | 785,391 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-25 | 30,000 | $0.00 | 30,000 | $6.81 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-26 | 20,000 | $0.00 | 20,000 | $6.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2008-01-02 | 2014-01-01 | No | 4 | M | Direct |
| 30,000 | 2008-01-02 | 2014-01-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 174 | Indirect | By Wife |
Footnotes
- The sale was a result of shares owned. The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/4/2013.
- Acquired as a result of exercising a stock option that is scheduled to expire on 1/1/14. The purchase and sale reproted on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plans adopted by the reporting person on 6/27/12.
Billionaire Hedge Funds
